VITRA 810

Key Technical Specifications

Laser Technology

• Wavelength: 810nm infrared wavelength for transscleral treatments

• Laser Source: Semiconductor diode laser technology

• Treatment Modes: SubLiminal subthreshold mode for advanced cyclophotocoagulation procedures

Clinical Applications

Primary Application: SubCyclo® Therapy

The Vitra 810's flagship feature is a new subthreshold cyclophotocoagulation treatment procedure named SubCyclo, a very promising laser therapy for advanced and end-stage glaucoma patients. This innovative approach targets the ciliary body with a continuous wave of 810 nanometre laser energy for a duration long enough to thermally denature tissue, causing reduced aqueous humor production, resulting in a decrease of Intra Ocular Pressure (IOP).

Versatile Treatment Options

Although designed for the SubCyclo® laser therapy, Vitra™ 810 can also be used to perform all the usual 810 nm glaucoma and retina treatments. The system's versatility extends to multiple treatment modalities including:

• Transscleral Cyclophotocoagulation: Advanced glaucoma management

• Transpupillary Thermotherapy (TTT): Retinal tumor treatment

• Standard Retinal Photocoagulation: Comprehensive retinal therapy

• SubCyclo® Procedures: Gentle, repeatable cyclophotocoagulation

System Configuration and Compatibility

Delivery Systems

When used in Retina treatment mode, Vitra™ 810 can be connected to various delivery systems, such as slit lamps and other ophthalmic platforms. The system offers flexible mounting options:

• Slit Lamp Compatibility: Adaptateur pour lampe à fente: disponible pour plate-forme de type Haag-Streit ou Zeiss

• Operating Room Use: Pour la lampe à fente ou le bloc opératoire

• Wireless Controls: Pédale sans fil en option (optional wireless footswitch)

Multi-Purpose Applications

The system's design philosophy emphasizes versatility: Utilisation polyvalente: SubCyclo, ThermoCyclo, rétine et TTT, making it a comprehensive solution for multiple ophthalmic laser procedures.

Advanced Treatment Features

Subthreshold Technology

The Vitra 810's SubLiminal mode represents a significant advancement in cyclophotocoagulation therapy. This subthreshold approach allows for Cyclophotocoagulation douce pouvant être répétée (gentle cyclophotocoagulation that can be repeated), providing safer treatment options for patients with advanced glaucoma.

Treatment Precision

The 810nm wavelength is specifically chosen for its optimal tissue penetration characteristics, allowing precise targeting of ciliary body structures while minimizing collateral damage to surrounding tissues.

Clinical Significance

Glaucoma Management

The Vitra 810 addresses a critical need in glaucoma therapy by providing treatment options for patients with advanced disease where conventional therapies may be insufficient. The SubCyclo® procedure offers a less invasive alternative to traditional cyclophotocoagulation methods.

Treatment Repeatability

One of the key advantages of the subthreshold approach is the ability to repeat treatments as needed, providing flexibility in long-term glaucoma management strategies.

Manufacturing and Support

Manufactured by Quantel Medical, France, the Vitra 810 represents decades of expertise in ophthalmic laser technology. As part of the Lumibird Medical Group, the system benefits from ongoing research and development in photonic medical technologies.

Conclusion

The Vitra 810™ stands as a revolutionary advancement in ophthalmic laser therapy, particularly for glaucoma management. Its combination of proven 810nm diode laser technology with innovative SubCyclo® capabilities provides clinicians with powerful new tools for treating challenging cases. The system's versatility, allowing for both traditional and subthreshold treatments, makes it a valuable addition to comprehensive ophthalmology practices focused on advanced glaucoma and retinal care.